cbdMD, Inc. 8K

cbdMD, Inc. agreed to acquire substantially all assets of the Twinlab supplements business out of an Assignment-for-the-Benefit-of-Creditors process, paying with assumed secured debt and cbdMD stock, subject to court approval and possible overbids.

On September 1, 2026, cbdMD, Inc. and its wholly owned subsidiary To Be Brands, LLC entered into an Asset Purchase Agreement to acquire substantially all of the assets related to the Twinlab nutritional supplements business from an assignee for the benefit of creditors of Twinlab’s subsidiaries, with the transaction structured as an Assignment for the Benefit of Creditors (ABC) sale in Florida and subject to approval of an ABC Court and potential higher and better bids; cbdMD will acquire intellectual property, contracts, inventory, accounts receivable, subsidiary equity interests, goodwill, and other operating assets free and clear of most encumbrances in exchange for assuming specified liabilities including $1.75 million of surviving secured debt to Akretive Holdings, LLC and issuing 2,229,805 shares of cbdMD common stock (subject to increase to maintain a 19.9% stake) to the secured creditor, while leaving behind pre-closing, tax, litigation, employee, environmental, product liability, and other excluded liabilities in the assignment estate for the benefit of creditors.

Filing Facts

CIK

1644903

Ticker

-

Form

8K

Source Type

sec

Accession

0001437749-26-029455

Alert Tier

8